Recessive TMOD1 mutation causes childhood cardiomyopathy
Open Access
- 2 January 2024
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 7 (1) , 1-13
Abstract
Familial cardiomyopathy in pediatric stages is a poorly understood presentation of heart disease in children that is attributed to pathogenic mutations. Through exome sequencing, we report a homozygous variant in tropomodulin 1 (TMOD1; c.565C>T, p.R189W) in three individuals from two unrelated families with childhood-onset dilated and restrictive cardiomyopathy. To decipher the mechanism of pathogenicity of the R189W mutation in TMOD1, we utilized a wide array of methods, including protein analyses, biochemistry and cultured cardiomyocytes. Structural modeling revealed potential defects in the local folding of TMOD1R189W and its affinity for actin. Cardiomyocytes expressing GFP-TMOD1R189W demonstrated longer thin filaments than GFP-TMOD1wt-expressing cells, resulting in compromised filament length regulation. Furthermore, TMOD1R189W showed weakened activity in capping actin filament pointed ends, providing direct evidence for the variant’s effect on actin filament length regulation. Our data indicate that the p.R189W variant in TMOD1 has altered biochemical properties and reveals a unique mechanism for childhood-onset cardiomyopathy.Keywords
Funding Information
- Jane ja Aatos Erkon Säätiö
- Sigrid Juséliuksen Säätiö
- University of Helsinki | Helsingin Yliopiston Tiedesäätiö
- Research Council of Finland
- Finnish Cultural Foundation | Etelä-Karjalan Rahasto
- Alfred Kordelinin Säätiö
- Maud Kuistilan Muistosäätiö
- Lastentautien Tutkimussäätiö
- U.S. Department of Health & Human Services | National Institutes of Health (R01HL123078, R01HL164644)
- U.S. Department of Health & Human Services | National Institutes of Health
- American Heart Association (19POST34450023)
This publication has 42 references indexed in Scilit:
- Identification of Residues within Tropomodulin-1 Responsible for Its Localization at the Pointed Ends of the Actin Filaments in Cardiac MyocytesJournal of Biological Chemistry, 2011
- Leiomodin-2 is an antagonist of tropomodulin-1 at the pointed end of the thin filaments in cardiac muscleJournal of Cell Science, 2010
- Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiologyJournal of Cell Biology, 2010
- Coding Sequence Rare Variants Identified in MYBPC3 , MYH6 , TPM1 , TNNC1 , and TNNI3 From 312 Patients With Familial or Idiopathic Dilated CardiomyopathyCirculation: Cardiovascular Genetics, 2010
- Thin filament length dysregulation contributes to muscle weakness in nemaline myopathy patients with nebulin deficiencyHuman Molecular Genetics, 2009
- An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocolBMC Biotechnology, 2008
- Tropomodulin1 Is Required in the Heart but Not the Yolk Sac for Mouse Embryonic DevelopmentCirculation Research, 2008
- Aberrant myofibril assembly in tropomodulin1 null mice leads to aborted heart development and embryonic lethalityJournal of Cell Biology, 2003
- Requirement of pointed-end capping by tropomodulin to maintain actin filament length in embryonic chick cardiac myocytesNature, 1995
- Mechanisms of thin filament assembly in embryonic chick cardiac myocytes: tropomodulin requires tropomyosin for assembly.Journal of Cell Biology, 1995